Life Molecular Imaging is developing a product portfolio of innovative molecular imaging tracers that address major clinical needs in neurology and cardiology.
Life Molecular Imaging
Making the
Making the
Invisible
Visible
Molecular imaging provides unique insights into the human body, enabling physicians to provide an improved diagnosis and personalize patient care
about life molecular imaging
Your Partner for
Your Partner for
Molecular Imaging
Our mission is to develop novel PET tracers in the field of molecular imaging that improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life.
our specialties
We offer a wide
We offer a wide
range of imaging tools
Providing an opportunity to directly visualize and measure brain function and to depict pathophysiological processes of neurodegenerative diseases
LEARN MORENeuro Imaging
Molecular imaging also has potential diagnostic applications in cardio- and cerebro-vascular diseases.
LEARN MORECardiovascular Imaging
Neuraceq®
Knowing can help you
Knowing can help you
plan the path ahead
Our lead product Neuraceq® is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate beta amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.
+
ACTIVE PRODUCTION SITES WORLD WIDE
+
Major drug development trials using Neuraceq®
RESEARCH & DEVELOPMENT
Research & Development Focus Areas
Our research and development portfolio focuses on neurodegenerative and cardiovascular diagnostics, including a next-generation Tau tracer for Alzheimer’s disease and progressive supranuclear palsy.